Verve Therapeutics



Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.

Sekar Kathiresan
Co-Founder, CEO & Board Member
Sekar Kathiresan
Andrew Ashe
President & COO
Andrew Bellinger
Chief Scientific Officer & Chief Medical Officer
Angela Cook
Chief of Staff
Leslie Stolz
VP, Regulatory Affairs
Yasser El-Gamal
VP, Legal Affairs & Chief Intellectual Property Counsel
Padma Malyala
VP, Formulation & Analytics Development
Hari Jayaram
VP, Editing & Discovery
Scott Vafai
VP, Translational Medicine
Ellen Rohde
VP, Pharmacology & Toxicology
Victoria Bartlett
VP, Program & Alliance Management

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.